The New Technologies for Cervical Cancer Screening randomised controlled trial. An overview of results during the first phase of recruitment
- 31 October 2007
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 107 (1) , S230-S232
- https://doi.org/10.1016/j.ygyno.2007.07.021
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Management of women who test positive for high-risk types of human papillomavirus: the HART studyThe Lancet, 2003
- Evaluation of Human Papillomavirus Testing in Primary Screening for Cervical AbnormalitiesJAMA, 2002
- Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 womenBritish Journal of Cancer, 2001
- Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopyInternational Journal of Cancer, 2000
- Evaluation of alternative methods of cervical cancer screening for resource-poor settingsCancer, 2000
- Human Papillomavirus DNA Testing for Cervical Cancer Screening in Low-Resource SettingsJNCI Journal of the National Cancer Institute, 2000
- HPV DNA Testing in Cervical Cancer ScreeningJAMA, 2000
- HPV testing in primary screening of older womenBritish Journal of Cancer, 1999
- Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 womenBritish Journal of Cancer, 1999
- Human papillomavirus testing in primary cervical screeningThe Lancet, 1995